Downloads

  1. Advance Long-Term Cell Kinetics With Integrated Fluid Handling 10/24/2025

    Examine how a novel setup enables uninterrupted long-term cell-based assays by combining CO₂ regulation and evaporation control to improve cell viability and data consistency for real-time analysis.

  2. Supporting Complex Manufacturing For Liquid And Lyophilized Drug Products 10/24/2025

    Aseptic fill and finish operations gain efficiency and precision with modular isolator technology, inline weight checks, and lyophilization, which are ideal for mRNA-LNPs and other sensitive modalities.

  3. Analyzing CAR-T Surface Proteins With Immunoprecipitation Coupled With Mass Spectrometry 10/24/2025

    Among other benefits, the approach can help compare CAR constructs, evaluate the effects of manufacturing processes, and monitor changes in protein interactions.

  4. Smarter CMC Strategies To Accelerate Next-Gen Biologics To The Clinic 10/23/2025

    Learn how process design and cross-functional collaboration mitigate risks and accelerate the path from early development to FIH manufacturing through real-world case studies of practical approaches.

  5. Cell Culture Media Filtration: Evaluating Cell Culture Performance 10/23/2025

    Cell culture performance remained consistent across PES and PVDF filters, even under worst-case filtration conditions. Discover a practical framework for evaluating membrane impact on CHO cell growth.

  6. Program Manager Alignment And Integration: Best Practices When Working With A CDMO 10/23/2025

    This Q&A discusses best practices for integrating program managers into a sponsor company and how program managers help bridge the gaps between various stakeholders.

  7. Two Sites, One Standard of Excellence 10/22/2025

    Secure your supply chain with a trusted partner in sterile manufacturing. Discover a dual-site strategy that offers crucial redundancy, high regulatory confidence, and a proven approach to efficient tech transfer.

  8. Your Journey To GMP With Emphasis On Linker Payload Development 10/22/2025

    Develop lower risk strategies with our insights into the key considerations you need to factor in when conjugating your linker payload to its antibody in our review of the pros and cons of semi-synthetic and synthetic linker payloads.

  9. Optimizing CMC Strategy For Successful Scale-Up 10/22/2025

    In this segment from the Bioprocess Online Live event “Evolving CMC Strategies To Enable Next-Gen ADCs,” panelists Michael Torres, Ph.D. (CrossBridge Bio), Morris Rosenberg, Ph.D. (CrossBridge Bio), and Borys Shor, Ph.D. (OS Therapies and Manhattan BioSolutions) share advice on developing CMC strategies in a way that strengthens manufacturability through careful assay development and collaboration with CDMOs.

  10. Innovating Next-Generation ADC Constructs 10/22/2025

    In this segment from the Bioprocess Online Live event “Evolving CMC Strategies To Enable Next-Gen ADCs,” panelists Michael Torres, Ph.D. (CrossBridge Bio), Morris Rosenberg, Ph.D. (CrossBridge Bio), and Borys Shor, Ph.D. (OS Therapies and Manhattan BioSolutions) share their thoughts on what constitutes a next-generation ADC and discuss innovations in the space, particularly in linkers, payloads, and consistent molecular homogeneity with respect to drug-antibody ratio (DAR).